Indira Mysorekar Email and Phone Number
Indira Mysorekar work email
- Valid
Indira Mysorekar personal email
- Valid
My lab group and I have made a number of novel and paradigm shifting discoveries in microbiology and microbial pathogenesis of Urinary tract infections (UTIs). I was the first to demonstrate that Uropathogenic Escherichia coli (UPEC); the principal causative agents of UTIs established persistent reservoirs within the bladder wall that could re-emerge to cause recurrent UTIs. We then went on to identify that the uropathogens use the autophagy pathway is a conduit for UPEC to access the autophagosomal niche; and that UPEC shuttles with ferritin-bound iron into the autophagosomal and lysosomal compartments within the bladder. Our most recent work has focused on dissecting mechanisms and therapeutic interventions to limit age-associated immune dysfunction and senescence in the aging bladder (Aged, postmenopausal women suffer from a high risk for recurrent UTIs and chronic inflammation). Our work is delineating how hormonal changes with age affect the regenerative capacity of urothelial cells. We demonstrated at the very beginning of the global Zika virus epidemic, that ZIKV takes a trans-placental route to infect the fetuses in pregnant mothers- this finding provided critical foundation to understand its virulence and to develop and test vaccines; anti-viral therapies. During the COVID-19 pandemic, my lab has shown that SARS CoV2 infects the placenta and adversely affects the regulation of the renin angiotensin pathway thereby uncovering a key link with the increased risk of Preeclampsia in pregnant women with COVID-19. Our work has been recognized in all three fields by being awarded a K99/R00, multiple R01s and program projects from NIDDK/NCI/NIA/NICHD/NIAID); Investigator awards from Burroughs-Wellcome Fund and the March of Dimes; 2021 Christian J. Herr award for outstanding achievements in reproductive immunology and two Endowed professorships: James P. Crane Endowed Professor of Maternal Fetal Medicine and inaugural E.L. Wagner Endowed Professor in Infectious Diseases and most recently being inducted as a Fellow at the American Academy of Microbiology I am a devoted and passionate mentor and have mentored numerous students and fellows and young faculty and received multiple Mentor of the Year awards. I am highly committed to scientific exchange forums (national and international), leadership and excellence in research and fiercely advocate for promoting women’s health research.
Baylor College Of Medicine
View-
Associate Director Of Graduate Program In Development Disease Models And TherapeuticsBaylor College Of MedicineHouston, Tx, Us -
Co Director, T32 Niaid/Nih Training Grant In Infectious DiseasesBaylor College Of Medicine Mar 2023 - PresentHouston, Texas, United States -
Co- Director, Clinical And Translational Research ProgramBaylor College Of Medicine Jan 2023 - PresentClinical Translational Research Program -
Chief Of Basic And Translational Research And Vice Chief, Section For Infectious DiseasesBaylor College Of Medicine Jul 2021 - PresentHouston, Texas, United States -
Vice Chair For Research GroupBaylor College Of Medicine Jul 2021 - PresentHouston, Texas, United States -
E. L. Wagner Endowed Professor Of MedicineBaylor College Of Medicine Jul 2021 - PresentHouston, Texas, United States -
James P. Crane Professor Of Obstetrics And GynecologyWashington University School Of Medicine In St. Louis Jan 2019 - Jun 2021 -
Director, Centre For Reproductive Health And ScienceCentre For Reproductive Health And Science, Washington University School Of Medicine Aug 2018 - Jun 2021https://medicine.wustl.edu/news/new-center-focuses-womens-mens-reproductive-health/ -
Professor Of Obstetrics And Gynecology; Pathology And ImmunologyWashington University School Of Medicine In St. Louis Jan 2018 - Jun 2021Greater St. Louis Areahttps://reproductivesciences.wustl.edu/laboratories/mysorekar-lab/ -
Associate ProfessorWashington University School Of Medicine Oct 2014 - Dec 2017Department Of Obstetrics And GynecologyOur work encompasses studies of mechanisms underlying biology and pathophysiology of the urinary bladder to studies of novel infectious etiologies for premature birth. We use mouse models, cell culture models, and conduct translational studies using human urine, blood, and tissue samples to ask the key questions: 1) How does the bladder tissue regenerate upon injury, especially injury caused by uropathogenic e. coli (UPEC) bacteria during an urinary tract infection (UTI), 2) UTIs are common and frequently recurrent. What is the mechanism underlying UPEC persistence and re-emergence to cause recurrent UTIs, and 3) Preterm birth (PTB) is common and commonly associated with infection but etiology is unknown. Who causes infection-induced PTB and how? We have recently identified a novel role for the autophagy gene/protein, ATG16L1 (mutations in which are strongly associated with inflammatory bowel disease) in conferring resistance to UTIs by limiting UPEC persistence and re-emergence from the bladder wall. We have further shown that humans carrying gene variants in ATG16L1 are significantly more resistant to UTIs. This work is providing the first explanation for why deleterious mutations in the human ATG16L1 gene are highly prevalent, despite their being associated with Crohn’s disease, a form of inflammatory bowel disease: their presence might confer resistance to recurrent UTIs (and infections of the gut), thus setting up selective pressure à la Sickle cell anemia trait and malaria resistance. Our work in the placenta is defining cellular mechanisms that underlying placental susceptibility to bacterial colonization and uncovering new insights into pathogens involved in PTB, and may identify new targets for microbiome-directed therapeutic interventions to prevent PTB by limiting infections. -
Assistant ProfessorWashington University School Of Medicine Jul 2008 - Sep 2014Department Of Obstetrics And Gynecology -
Postdoctoral Research FellowWashington University School Of Medicine Apr 2003 - 2007Department Of Molecular Microbiology -
Doctoral StudentWashington University School Of Medicine 1996 - 2002Developmental Biology -
Research TechnicianWashington University School Of Medicine Jul 1995 - May 1996Department Of Medicine
Indira Mysorekar Skills
Indira Mysorekar Education Details
-
Development And Molecular Biology -
Molecular Biology -
Molecular Biology
Frequently Asked Questions about Indira Mysorekar
What company does Indira Mysorekar work for?
Indira Mysorekar works for Baylor College Of Medicine
What is Indira Mysorekar's role at the current company?
Indira Mysorekar's current role is Associate Director of graduate program in Development Disease Models and Therapeutics.
What is Indira Mysorekar's email address?
Indira Mysorekar's email address is im****@****hoo.com
What schools did Indira Mysorekar attend?
Indira Mysorekar attended Washington University In St. Louis, Lunds Universitet, Lunds Universitet.
What are some of Indira Mysorekar's interests?
Indira Mysorekar has interest in Children, Education, Science And Technology, Arts And Culture, Health.
What skills is Indira Mysorekar known for?
Indira Mysorekar has skills like Molecular Biology, Cell Biology, Cell Culture, Molecular Cloning, Placental Biology, Laboratory, Medical Research, Western Blotting, Confocal Microscopy, Biochemistry, Genetics, Fluorescence Microscopy.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial